about
Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up.Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin.Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity.Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell deathAre cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?Cardiac troponins--Translational biomarkers in cardiology: Theory and practice of cardiac troponin high-sensitivity assays.Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo.Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane.Troponins in children and neonates.Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment.Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits.Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits.Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits.Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits.Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats.Veterinary and toxicological applications for the detection of cardiac injury using cardiac troponin.Proteomic insights into chronic anthracycline cardiotoxicity.Doxorubicin-induced behavioral disturbances in rats: Protective effect of melatonin and captoprilMelatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failureEffects of captopril, spironolactone, and simvastatin on the cardiovascular system of non-diseased Wistar ratsExperimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive valueIn vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicityIron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH)Cardiac Troponin T in Neonates after Acute and Long-Term TocolysisCardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbitsCardiac troponin T in pregnant women having intravenous tocolytic therapyInvestigation of structure-activity relationships of dexrazoxane analogues reveals topoisomerase IIβ interaction as a prerequisite for effective protection against anthracycline cardiotoxicity
P50
Q33578496-9682588C-0DC5-4C40-BB9D-F2D5B2013DF1Q33930296-383FC8AD-1D95-4BE6-8EF4-098D1E12DC3BQ36150546-3021AB4F-06CC-4415-B71C-53FA3049124DQ37330749-1F10EF5D-0309-4E46-A98F-C919344A2F2CQ38732745-C6C600AF-A6A0-46AC-900E-8DC5D0CE4996Q38733103-EE8F96C3-71BF-453E-9E52-74A6489C7799Q39988639-2C01EE37-4FDF-4FB7-989E-F4E1A5C27427Q40151835-64B77455-DC2E-4C04-B218-766872D9413FQ42620104-86B8790C-8475-427F-8BDE-D3D0017AD171Q42710370-61345336-EA0F-4B5F-95C7-EEB2E8D580DAQ42914471-44E63E24-1D80-485A-99FD-D21DF34C9772Q44286072-22E56572-1EF4-4D32-BE76-0113AD1BB103Q45231768-6C4D6482-9338-456F-B8A9-853AC1B41392Q46545274-4B22624B-FD92-49EE-BF9E-B54FFF3A7B68Q46832149-D6FC439A-6D9A-4007-A533-FB0ACE4796DCQ47098684-149EFAEB-DB8A-4308-8CEA-47685428B3BDQ53822445-AD7D7389-B6BA-46F9-B9DA-A7ADB4CF6617Q54389872-4FB92254-182D-4581-86D4-49B7105146D2Q57825816-F63EBDA4-68B7-4B64-8D15-F2DA023D0820Q57825824-5B38724A-DCB2-43D6-90C4-15190A412339Q58841595-B36347B2-47A7-4473-BD5D-9BBAEBC73D96Q58841598-67AAD47B-64D5-433B-A382-B1ADE1AD0132Q58841618-EDB443F8-0BCC-4E60-BECE-8370E0E84DEAQ58841625-8F9D992F-451E-4E50-8B6D-9FAF11A5BE74Q58841716-A18C9C9B-3007-4231-8719-E31AD5171FD0Q58841724-E9E8A9C0-B98E-4AC6-A002-6D4DC1FCE829Q58841730-51174077-018B-4CF1-9A01-CC4E92AF8886Q91610451-C3CEDC69-CD63-4D91-925E-F614AF518178
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michaela Adamcova
@ast
Michaela Adamcova
@en
Michaela Adamcova
@es
Michaela Adamcova
@nl
Michaela Adamcova
@sl
type
label
Michaela Adamcova
@ast
Michaela Adamcova
@en
Michaela Adamcova
@es
Michaela Adamcova
@nl
Michaela Adamcova
@sl
prefLabel
Michaela Adamcova
@ast
Michaela Adamcova
@en
Michaela Adamcova
@es
Michaela Adamcova
@nl
Michaela Adamcova
@sl
P106
P1153
7003586451
P21
P31
P496
0000-0003-3320-9735